ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 123 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $157,448 | -89.4% | 51,963 | -91.9% | 0.01% | -92.9% |
| Q4 2022 | $1,491,137 | +1654.3% | 639,973 | +1346.3% | 0.07% | +2233.3% |
| Q3 2022 | $85,000 | -33.1% | 44,250 | -5.8% | 0.00% | -25.0% |
| Q2 2022 | $127,000 | +4.1% | 46,988 | +14.5% | 0.00% | +100.0% |
| Q1 2022 | $122,000 | -23.3% | 41,031 | +0.2% | 0.00% | -33.3% |
| Q4 2021 | $159,000 | +2.6% | 40,934 | +13.1% | 0.00% | 0.0% |
| Q3 2021 | $155,000 | +72.2% | 36,207 | +27.3% | 0.00% | +200.0% |
| Q2 2021 | $90,000 | +9.8% | 28,451 | +9.4% | 0.00% | 0.0% |
| Q1 2021 | $82,000 | -46.8% | 26,009 | -37.0% | 0.00% | -66.7% |
| Q4 2020 | $154,000 | +6.9% | 41,299 | -9.0% | 0.00% | -40.0% |
| Q3 2020 | $144,000 | +269.2% | 45,373 | +121.1% | 0.01% | +400.0% |
| Q2 2020 | $39,000 | – | 20,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |